The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods

Vaccine

Volumn 26, Issue 17, 2008, Pages 2100-2110

  Wang, Shixia ^a,b   Zhang, Chunghua ^a   Zhang, Lu ^a   Li, Jun ^a   Huang, Zuhu ^a   Lu, Shan ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Antibody; B cell; DNA vaccine; Influenza; T cell

Indexed keywords

DNA VACCINE; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DNA IMMUNIZATION; ELECTROPORATION; ENZYME LINKED IMMUNOSPOT ASSAY; GENE GUN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS A H5N1; INJECTION PISTOL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; BIOLISTICS; DISEASE MODELS, ANIMAL; ELECTROPORATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INJECTIONS, INTRAMUSCULAR; MICE; RABBITS; VACCINES, DNA;

EID: 41549123253     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.02.033     Document Type: Article

References (77)

1. Roy M.J., Wu M.S., Barr L.J., Fuller J.T., Tussey L.G., Speller S., et al. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19 7-8 (2000) 764-778
2. Drape R.J., Macklin M.D., Barr L.J., Jones S., Haynes J.R., and Dean H.J. Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine 24 21 (2006) 4475-4481
3. Tang D.C., Devit M., and Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 356 6365 (1992) 152-154
4. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259 5102 (1993) 1745-1749
5. Robinson H.L., Hunt L.A., and Webster R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11 9 (1993) 957-960
6. Lu S., Santoro J.C., Fuller D.H., Haynes J.R., and Robinson H.L. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 209 1 (1995) 147-154
7. Wang B., Ugen K.E., Srikantan V., Agadjanyan M.G., Dang K., Refaeli Y., et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90 9 (1993) 4156-4160
8. Davis H.L., Demeneix B.A., Quantin B., Coulombe J., and Whalen R.G. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum Gene Ther 4 6 (1993) 733-740
9. Wang S., Kennedy J., West K., Montefiori D.C., Bansal A., Goepfert P., et al. Balanced cellular and antibody responses induced by the polyvalent DNA prime-protein boost HIV-1 vaccine formulation DP6-001 in healthy human volunteers. Vaccine 26 8 (2008) 1098-1110
10. Pertmer T.M., Eisenbraun M.D., McCabe D., Prayaga S.K., Fuller D.H., and Haynes J.R. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13 15 (1995) 1427-1430
11. Dobano C., Widera G., Rabussay D., and Doolan D.L. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation. Vaccine 25 36 (2007) 6635-6645
12. Fuller D.H., Loudon P., and Schmaljohn C. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Methods 40 1 (2006) 86-97
13. Dean H.J., Haynes J., and Schmaljohn C. The role of particle-mediated DNA vaccines in biodefense preparedness. Adv Drug Deliv Rev 57 9 (2005) 1315-1342
14. Talaat A.M., Lyons R., and Johnston S.A. A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses. Vaccine 20 3-4 (2001) 538-544
15. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., and Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 90 24 (1993) 11478-11482
16. Macklin M.D., McCabe D., McGregor M.W., Neumann V., Meyer T., Callan R., et al. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J Virol 72 2 (1998) 1491-1496
17. Lodmell D.L., Ray N.B., Parnell M.J., Ewalt L.C., Hanlon C.A., Shaddock J.H., et al. DNA immunization protects nonhuman primates against rabies virus. Nat Med 4 8 (1998) 949-952
18. Fuller D.H., Rajakumar P.A., Wilson L.A., Trichel A.M., Fuller J.T., Shipley T., et al. Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine. J Virol 76 7 (2002) 3309-3317
19. Tacket C.O., Roy M.J., Widera G., Swain W.F., Broome S., and Edelman R. Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine 17 22 (1999) 2826-2829
20. Rottinghaus S.T., Poland G.A., Jacobson R.M., Barr L.J., and Roy M.J. Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination. Vaccine 21 31 (2003) 4604-4608
21. Roberts L.K., Barr L.J., Fuller D.H., McMahon C.W., Leese P.T., and Jones S. Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. Vaccine 23 40 (2005) 4867-4878
22. McConkey S.J., Reece W.H., Moorthy V.S., Webster D., Dunachie S., Butcher G., et al. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med 9 6 (2003) 729-735
23. Neumann E., Schaefer-Ridder M., Wang Y., and Hofschneider P.H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1 7 (1982) 841-845
24. Potter H. Electroporation in biology: methods, applications, and instrumentation. Anal Biochem 174 2 (1988) 361-373
25. Tsong T.Y. Electroporation of cell membranes. Biophys J 60 2 (1991) 297-306
26. Sukharev S.I., Klenchin V.A., Serov S.M., Chernomordik L.V., and Chizmadzhev YuA. Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores. Biophys J 63 5 (1992) 1320-1327
27. Wolf H., Rols M.P., Boldt E., Neumann E., and Teissie J. Control by pulse parameters of electric field-mediated gene transfer in mammalian cells. Biophys J 66 2 Pt 1 (1994) 524-531
28. Harrison R.L., Byrne B.J., and Tung L. Electroporation-mediated gene transfer in cardiac tissue. FEBS Lett 435 1 (1998) 1-5
29. Rols M.P., Delteil C., Golzio M., Dumond P., Cros S., and Teissie J. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 16 2 (1998) 168-171
30. Aihara H., and Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16 9 (1998) 867-870
31. Mir L.M., Bureau M.F., Gehl J., Rangara R., Rouy D., Caillaud J.M., et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 96 8 (1999) 4262-4267
32. Gehl J., and Mir L.M. Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun 261 2 (1999) 377-380
33. Widera G., Austin M., Rabussay D., Goldbeck C., Barnett S.W., Chen M., et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164 9 (2000) 4635-4640
34. Bloquel C., Fabre E., Bureau M.F., and Scherman D. Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications. J Gene Med 6 Suppl. 1 (2004) S11-S23
35. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 6 4 (1999) 508-514
36. Rizzuto G., Cappelletti M., Maione D., Savino R., Lazzaro D., Costa P., et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci USA 96 11 (1999) 6417-6422
37. Khan A.S., Pope M.A., and Draghia-Akli R. Highly efficient constant-current electroporation increases in vivo plasmid expression. DNA Cell Biol 24 12 (2005) 810-818
38. Dupuis M., Denis-Mize K., Woo C., Goldbeck C., Selby M.J., Chen M., et al. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol 165 5 (2000) 2850-2858
39. Hooper J., Golden J., Ferro A., and King A. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 25 10 (2007) 1814-1823
40. Tollefsen S., Vordermeier M., Olsen I., Storset A.K., Reitan L.J., Clifford D., et al. DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants. Scand J Immunol 57 3 (2003) 229-238
41. Luckay A., Sidhu M.K., Kjeken R., Megati S., Chong S.Y., Roopchand V., et al. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol 81 10 (2007) 5257-5269
42. Tsang C., Babiuk S., van Drunen Littel-van den Hurk S., Babiuk L.A., and Griebel P. A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months. Vaccine 25 30 (2007) 5485-5494
43. Babiuk S., Tsang C., van Drunen Littel-van den Hurk S., Babiuk L.A., and Griebel P.J. A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep. Bioelectrochemistry 70 2 (2007) 269-274
44. Wang S., Taaffe J., Parker C., Solarzano A., Cao H., Garcia-Sastre A., et al. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. J Virol 80 23 (2006) 11628-11637
45. Wang S., Joshi S., and Lu S. Delivery of DNA to Skin by particle bombardment. In: Heiser W.C. (Ed). Gene Delivery to Mammalian Cells (2004), Humana Press
46. Wang S., Heilman D., Liu F., Giehl T., Joshi S., Huang X., et al. A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague. Vaccine 22 25-26 (2004) 3348-3357
47. Chen X., Rock M.T., Hammonds J., Tartaglia J., Shintani A., Currier J., et al. Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses. J Virol 79 9 (2005) 5537-5547
48. Rock M.T., and Crowe Jr. J.E. Identification of a novel human leucocyte antigen-A*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein. Immunology 108 4 (2003) 474-480
49. Tamura M., Kuwano K., Kurane I., and Ennis F.A. Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1-specific, H2-specific, and H1- and H2-cross-reactive murine cytotoxic T-lymphocyte clones. J Virol 72 11 (1998) 9404-9406
50. Felgner P.L., Tsai Y.J., Sukhu L., Wheeler C.J., Manthorpe M., Marshall J., et al. Improved cationic lipid formulations for in vivo gene therapy. Ann N Y Acad Sci 772 (1995) 126-139
51. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., et al. Direct gene transfer into mouse muscle in vivo. Science 247 4949 Pt 1 (1990) 1465-1468
52. Nabel G.J., Nabel E.G., Yang Z.Y., Fox B.A., Plautz G.E., Gao X., et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 90 23 (1993) 11307-11311
53. Raz E., Carson D.A., Parker S.E., Parr T.B., Abai A.M., Aichinger G., et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 91 20 (1994) 9519-9523
54. Herrmann J.E., Chen S.C., Jones D.H., Tinsley-Bown A., Fynan E.F., Greenberg H.B., et al. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles. Virology 259 1 (1999) 148-153
55. Chen S.C., Jones D.H., Fynan E.F., Lu S., Greenberg H.B., Santoro J.C., et al. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol 72 7 (1998) 5757-5761
56. Selinsky C., Luke C., Wloch M., Geall A., Hermanson G., Kaslow D., et al. A DNA-based vaccine for the prevention of human cytomegalovirus-associated diseases. Hum Vaccin 1 1 (2005) 16-23
57. Haynes J.R. Particle-mediated DNA vaccine delivery to the skin. Expert Opin Biol Ther 4 6 (2004) 889-900
58. Haynes J.R., McCabe D.E., Swain W.F., Widera G., and Fuller J.T. Particle-mediated nucleic acid immunization. J Biotechnol 44 1-3 (1996) 37-42
59. Pertmer T.M., Roberts T.R., and Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol 70 9 (1996) 6119-6125
60. Smorlesi A., Papalini F., Amici A., Orlando F., Pierpaoli S., Mancini C., et al. Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma. Vaccine 24 11 (2006) 1766-1775
61. MacGregor R.R., Boyer J.D., Ugen K.E., Lacy K.E., Gluckman S.J., Bagarazzi M.L., et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis 178 1 (1998) 92-100
62. Boyer J.D., Chattergoon M.A., Ugen K.E., Shah A., Bennett M., Cohen A., et al. Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial. Clin Immunol (Orlando, Fla) 90 1 (1999) 100-107
63. Wang R., Doolan D.L., Le T.P., Hedstrom R.C., Coonan K.M., Charoenvit Y., et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282 5388 (1998) 476-480
64. Le T.P., Coonan K.M., Hedstrom R.C., Charoenvit Y., Sedegah M., Epstein J.E., et al. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine 18 18 (2000) 1893-1901
65. Eisenbraun M.D., Fuller D.H., and Haynes J.R. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol 12 9 (1993) 791-797
66. Yang N.S., Burkholder J., Roberts B., Martinell B., and McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci USA 87 24 (1990) 9568-9572
67. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., and Falo Jr. L.D. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 2 10 (1996) 1122-1128
68. Zaharoff D.A., Barr R.C., Li C.Y., and Yuan F. Electromobility of plasmid DNA in tumor tissues during electric field-mediated gene delivery. Gene Ther 9 19 (2002) 1286-1290
69. Babiuk L.A., Pontarollo R., Babiuk S., Loehr B., and van Drunen Littel-van den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 21 7-8 (2003) 649-658
70. Wang Z., Troilo P.J., Wang X., Griffiths T.G., Pacchione S.J., Barnum A.B., et al. Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Ther 11 8 (2004) 711-721
71. Heller L.C., Ugen K., and Heller R. Electroporation for targeted gene transfer. Expert Opin Drug Deliv 2 2 (2005) 255-268
72. Prud'homme G.J. DNA vaccination against tumors. J Gene Med 7 1 (2005) 3-17
73. Prud'homme G.J., Glinka Y., Khan A.S., and Draghia-Akli R. Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther 6 2 (2006) 243-273
74. Feltquate D.M., Heaney S., Webster R.G., and Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 158 5 (1997) 2278-2284
75. Weiss R., Scheiblhofer S., Freund J., Ferreira F., Livey I., and Thalhamer J. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 20 25-26 (2002) 3148-3154
76. Wang S., Farfan-Arribas D.J., Shen S., Chou T.H., Hirsch A., He F., et al. Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine. Vaccine 24 21 (2006) 4531-4540
77. Lu S., Manning S., and Arthos J. Antigen engineering in DNA immunization. In: Lowrie DaW R. (Ed). Methods in Molecular Medicine DNA Vaccines (1999), Humana Press 355-374